The longrange goal of the research proposed in this application is to elucidate the nature of the metabolic imbalances and biochemical changes responsible for the late complications of diabetes. Epidemiological and experimental investigations both are consistent with the hypothesis that the development of late diabetic complications is largely the consequence of metabolic imbalances and dysfunction which greatly increase the susceptibility of vessels and nerves to injury by risk factors independent of the diabetic milieu. Such risk factors include hypertension, cigarette smoking, atherogenic lipoproteins, and hypoxic/ischemic injury. Several lines of evidence indicate that the diabetic milieu induces a hypoxia-like state """"""""diabetic pseudohypoxia"""""""" despite the presence of normal tissue oxygen levels. This hypoxia-like condition (an increased ratio of NADH/NAD+) appears to be largely the consequence of increased oxidation of sorbitol to fructose and increased oxidation of fatty acids. A cascade of metabolic imbalances and oxidative stress induced by this hypoxia-like state appears to play an important role in mediating early vascular and neural changes induced by diabetes and by acute hyperglycemia in nondiabetic rats. The experiments outlined in this proposal are designed to elucidate the role of these metabolic imbalances and oxidative stress associated with diabetic pseudohypoxia in mediating vascular and neural dysfunction. To this end diabetes will be induced in rats and vascular leakage and blood flow will be assessed in untreated rats and in rats treated with pharmacological agents known to impact (beneficially) on metabolic imbalances and dysfunction induced by hypoxia and ischemia to the heart and brain. Agents which impact more specifically on diabetes-induced vascular and neural changes also will be investigated. These agents include free radical scavengers, dichloroacetate, carnitines, C-peptide, and inhibitors of sorbitol dehydrogenase. In parallel experiments the effects of these agents will be examined on metabolism of tissues prone to development of diabetic complications including retina, peripheral nerve, and aorta. The potential significance of this research is that it may provide new insights regarding the pathogenesis of late complications of diabetes and may contribute to the development of new therapeutic approaches for the prevention and treatment of diabetic complications.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY006600-09
Application #
2160593
Study Section
Visual Sciences C Study Section (VISC)
Project Start
1986-08-01
Project End
1997-08-31
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
9
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ido, Yasuo; Nyengaard, Jens R; Chang, Kathy et al. (2010) Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation. Antioxid Redox Signal 12:39-51
Schmidt, R E; Dorsey, D A; Beaudet, L N et al. (2001) Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes. J Neuropathol Exp Neurol 60:1153-69
Schmidt, R E; Dorsey, D A; Beaudet, L N et al. (1998) Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy. J Neuropathol Exp Neurol 57:1175-89
Ido, Y; McHowat, J; Chang, K C et al. (1994) Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes 43:1469-77
Pugliese, G; Tilton, R G; Speedy, A et al. (1994) Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats. Metabolism 43:492-500
Misko, T P; Moore, W M; Kasten, T P et al. (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119-25
Tilton, R G; Chang, K; Hasan, K S et al. (1993) Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-32
Williamson, J R; Chang, K; Allison, W et al. (1993) Endoneurial blood flow changes in diabetic rats. Diabet Med 10 Suppl 2:49S-51S
Williamson, J R; Chang, K; Frangos, M et al. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-13
Hasan, K; Heesen, B J; Corbett, J A et al. (1993) Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249:101-6

Showing the most recent 10 out of 25 publications